Exosome Therapy for Diabetes & Wound Healing

Carrying the code of renewal to where healing has stalled. iPSC exosomes reactivate the tissue regeneration cascade in diabetic wounds.

The Cellular Failure Behind Chronic Wounds

Malaysia has one of the highest diabetes rates in Southeast Asia — over 3.9 million Malaysians live with diabetes. Diabetic foot ulcers and chronic wounds represent one of the most challenging complications, driven by impaired cellular signalling, poor vascularisation, and chronic inflammation.

In diabetic tissue, cells lose their ability to receive and respond to healing signals. iPSC exosomes deliver a concentrated healing payload that bypasses this receptor dysfunction and directly activates the regenerative cascade.

  • Activates keratinocyte and fibroblast proliferation
  • Stimulates angiogenesis (new capillary growth) into wound bed
  • Modulates chronic inflammation to allow healing
  • Deposits extracellular matrix proteins for wound closure
  • Reduces bacterial biofilm susceptibility
  • Accelerates wound closure in clinical observations by 30–50%
Dandelion messenger delivering healing signals to diabetic wounds

Wound Types We Address

🦶

Diabetic Foot Ulcers

Grade I–III DFUs that have failed to respond to standard wound care. Exosome therapy reactivates the healing cascade.

🩹

Venous Leg Ulcers

Chronic venous insufficiency wounds resistant to compression therapy. Exosomes stimulate new tissue formation.

🔥

Post-Surgical Wounds

Dehisced or slow-healing surgical wounds. Exosome topical or injectable application accelerates re-epithelialisation.

⚡

Pressure Ulcers

Stages II–IV pressure injuries in immobilised patients. Exosomes support tissue regeneration from the base of the wound.

Ready to Begin Your Renewal Journey?

Speak with a certified exosome therapy specialist near you.

Find a Clinic Contact Us